Maintaining Confidentiality of Emerging Results in COVID-19 Vaccine Trials

Maintaining Confidentiality of Emerging Results in COVID-19 Vaccine Trials

October 2020

We can make COVID-19 vaccines rapidly available only if we have rigorous evidence—which is threatened if we allow emerging data from candidate trials to be disclosed in ways that might influence trial design or conduct and potentially bias the results, write Susan Ellenberg, PhD, and colleagues.

Share this Content

About Us

To understand health and disease today, we need new thinking and novel science —the kind  we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics. LEARN MORE ABOUT US

© 2021 Trustees of the University of Pennsylvania. All rights reserved. | Disclaimer

Follow Us